ArticleJACC. Case reports2026
Cross-Organ Recovery After Transcatheter Tricuspid Valve Replacement With Diuretic and Antiviral Discontinuation: Beyond Cardiac Function.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reading TTVR Mechanically: Three Questions This Mini-Focus Helps Us Ask.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTranscatheter tricuspid valve replacement (TTVR) is an emerging option for patients with severe tricuspid regurgitation (TR) at prohibitive surgical risk. Severe TR is associated with systemic venous congestion, multiorgan dysfunction, and high mortality, yet isolated tricuspid surgery is rarely performed. CASE SUMMARY: A 68-year-old woman with prior double mechanical valve replacement, chronic kidney disease, and hepatitis B, treated with entecavir, presented with dyspnea and edema. Imaging revealed torrential TR with a 43-mm annulus. Because of high surgical risk, she underwent successful TTVR. TR abolition allowed cessation of diuretics and antiviral therapy after normalization of hepatic tests and viral load. DISCUSSION: This case illustrates how TTVR-mediated venous decongestion can reverse renal and hepatic alterations and enable cessation of supportive therapies. TAKE-HOME MESSAGES: TTVR can abolish TR, improve right-heart hemodynamics, and provide systemic benefits beyond cardiac function. Venous decongestion may enable cross-organ recovery and allow withdrawal of diuretics and antiviral therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.